These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 17531835

  • 1. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A, Carpenter A, Alexander JS.
    Int Rev Neurobiol; 2007; 79():1-11. PubMed ID: 17531835
    [Abstract] [Full Text] [Related]

  • 2. Immunopathogenesis of multiple sclerosis.
    Agrawal SM, Yong VW.
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [Abstract] [Full Text] [Related]

  • 3. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 4. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ, Suidan GL, McDole J, Pirko I.
    Int Rev Neurobiol; 2007 Aug; 79():73-97. PubMed ID: 17531838
    [Abstract] [Full Text] [Related]

  • 5. Role of B cells in pathogenesis of multiple sclerosis.
    Nikbin B, Bonab MM, Khosravi F, Talebian F.
    Int Rev Neurobiol; 2007 Aug; 79():13-42. PubMed ID: 17531836
    [Abstract] [Full Text] [Related]

  • 6. Immunology of multiple sclerosis.
    Sospedra M, Martin R.
    Annu Rev Immunol; 2005 Aug; 23():683-747. PubMed ID: 15771584
    [Abstract] [Full Text] [Related]

  • 7. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ.
    Bull Mem Acad R Med Belg; 2002 Aug; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis. I. The immune pathogenetic hypothesis.
    Bergamini L, Durelli L.
    Riv Neurol; 1989 Aug; 59(5):176-90. PubMed ID: 2483961
    [Abstract] [Full Text] [Related]

  • 9. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J, Villa A.
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [Abstract] [Full Text] [Related]

  • 10. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulins and complement in postmortem multiple sclerosis tissue.
    Barnett MH, Parratt JD, Cho ES, Prineas JW.
    Ann Neurol; 2009 Jan; 65(1):32-46. PubMed ID: 19194879
    [Abstract] [Full Text] [Related]

  • 12. [Etiology of multiple sclerosis].
    Laplaud DA, Confavreux C.
    Rev Prat; 2006 Jun 30; 56(12):1306-12. PubMed ID: 16948218
    [Abstract] [Full Text] [Related]

  • 13. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
    McCandless EE, Klein RS.
    Expert Rev Mol Med; 2007 Jul 19; 9(20):1-19. PubMed ID: 17637110
    [Abstract] [Full Text] [Related]

  • 14. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E, Tseveleki V, Euagelidou M, Emmanouil M, Voulgari-Kokota A, Haralambous S, Probert L.
    Neurodegener Dis; 2008 Jul 19; 5(1):32-7. PubMed ID: 18075273
    [Abstract] [Full Text] [Related]

  • 15. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N, Swaab DF, Hoek RM, Huitinga I.
    J Neuropathol Exp Neurol; 2009 Feb 19; 68(2):159-67. PubMed ID: 19151626
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis.
    Casiraghi C, Dorovini-Zis K, Horwitz MS.
    J Neuroimmunol; 2011 Jan 19; 230(1-2):173-7. PubMed ID: 20826008
    [Abstract] [Full Text] [Related]

  • 17. [Intercellular adhesion molecules and chemotaxic factors in the pathogenesis of multiple sclerosis].
    González-Amaro R, Sánchez-Madrid F.
    Rev Neurol; 2011 Jan 19; 35(10):985-93. PubMed ID: 12436404
    [Abstract] [Full Text] [Related]

  • 18. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C, Liblau RS.
    J Neurochem; 2007 Feb 19; 100(4):883-92. PubMed ID: 17181557
    [Abstract] [Full Text] [Related]

  • 19. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul 19; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

  • 20. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O, Cravens PD, Eagar TN.
    Expert Rev Neurother; 2008 Mar 19; 8(3):351-60. PubMed ID: 18345967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.